As with other drugs, Zolgensma (onasemnogene abeparvovec-xio) can cause side effects, such as elevated liver enzymes and vomiting. If side effects of Zolgensma become difficult to tolerate, talk with ...
Zolgensma is a prescription drug that’s used to treat spinal muscular atrophy (SMA) in young children. Zolgensma’s cost may depend on factors such as your child’s treatment plan and whether you have ...
Zolgensma is a gene therapy used to treat spinal muscular atrophy (SMA) in some children. A healthcare professional will administer the drug as a one-time intravenous infusion. Doctors determine the ...
Basel, March 24, 2020 – AveXis, a Novartis company, today announced a one-time infusion of Zolgensma® (onasemnogene abeparvovec-xioi) showed rapid, significant and clinically meaningful therapeutic ...
Zolgensma (onasemnogene abeparvovec-xioi) is a brand-name drug prescribed for spinal muscular atrophy in certain children. Zolgensma comes as a liquid suspension for intravenous (IV) infusion. It’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results